DurAVR™ THV System: EMBARK Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 150 participants.

Also called NCT05182307

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose device feasibility
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Anteris Technologies Ltd. (from the registry)
Registry
  • NCT NCT05182307
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Georgia (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05182307. Allocation not applicable; no masking; primary purpose device feasibility. Start 2021-11-15 (actual); primary completion 2028-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DurAVR™ THV System: EMBARK Study
Condition
Symptomatic Aortic Stenosis
Condition
Severe Aortic Valve Stenosis
Condition
Aortic Valve Calcification
Intervention (Device)
DurAVR™ THV System
Lead sponsor
Anteris Technologies Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05182307
Content hash
2bd01320c656c6c4b7846aa4d1bb4d7477680225ba65c4f02fc6dbce5abedd79